NCT05514847View on ClinicalTrials.gov

Low Dose Aspirin for Preterm Preeclampsia Preventionmg/day Dose in High-risk Patients

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

October 1, 2022

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2025

Conditions
PreeclampsiaPregnancy Related
Interventions
DRUG

Aspirin 81Mg Ec Tab

81 mg enteric coated aspirin, taken daily from before 14 weeks of gestational age through pregnancy

DRUG

Aspirin 162Mg Ec Tab

162 mg enteric coated aspirin, taken daily from before 14 weeks of gestational age through pregnancy

Trial Locations (1)

22903

University of Virginia, Charlottesville

All Listed Sponsors
lead

University of Virginia

OTHER

NCT05514847 - Low Dose Aspirin for Preterm Preeclampsia Preventionmg/day Dose in High-risk Patients | Biotech Hunter | Biotech Hunter